2-197705418-T-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_138395.4(MARS2):c.13T>A(p.Ser5Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,610,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_138395.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARS2 | NM_138395.4 | c.13T>A | p.Ser5Thr | missense_variant | 1/1 | ENST00000282276.8 | NP_612404.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARS2 | ENST00000282276.8 | c.13T>A | p.Ser5Thr | missense_variant | 1/1 | 6 | NM_138395.4 | ENSP00000282276.6 | ||
ENSG00000222017 | ENST00000409845.1 | n.166+6554T>A | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000287 AC: 7AN: 243958Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133186
GnomAD4 exome AF: 0.00000892 AC: 13AN: 1457804Hom.: 0 Cov.: 31 AF XY: 0.00000552 AC XY: 4AN XY: 725102
GnomAD4 genome AF: 0.000118 AC: 18AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2024 | The c.13T>A (p.S5T) alteration is located in exon 1 (coding exon 1) of the MARS2 gene. This alteration results from a T to A substitution at nucleotide position 13, causing the serine (S) at amino acid position 5 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 25, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1910254). This variant has not been reported in the literature in individuals affected with MARS2-related conditions. This variant is present in population databases (rs752435067, gnomAD 0.02%). This sequence change replaces serine, which is neutral and polar, with threonine, which is neutral and polar, at codon 5 of the MARS2 protein (p.Ser5Thr). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at